Huadong Medicine Co., Ltd (SHE: 000963)

Huadong Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4,739	4,663	3,996	4,032	3,198	2,403
Cash & Short-Term Investments	4,739	4,663	3,996	4,032	3,198	2,403
Cash Growth	20.59%	16.69%	-0.90%	26.09%	33.10%	-1.64%
Accounts Receivable	10,576	8,896	8,210	6,940	6,966	6,776
Other Receivables	526.01	306.2	284.18	223.92	87.63	92.2
Receivables	11,102	9,203	8,494	7,164	7,054	6,868
Inventory	4,907	4,290	4,495	3,975	4,068	4,039
Prepaid Expenses	-	-	-	-	-	0.12
Other Current Assets	505.72	340.46	582.21	316.04	336.21	425.65
Total Current Assets	21,253	18,497	17,568	15,487	14,656	13,736
Property, Plant & Equipment	5,271	5,204	5,021	4,813	4,661	4,005
Long-Term Investments	2,102	2,101	2,020	1,243	1,076	464.27
Goodwill	2,909	2,599	2,441	2,139	1,470	1,470
Other Intangible Assets	2,548	2,334	2,280	2,233	1,463	1,455
Long-Term Deferred Tax Assets	232.73	187.81	152.84	143.65	137.83	116.16
Long-Term Deferred Charges	1,242	1,013	657.81	12.43	8.81	12.29
Other Long-Term Assets	1,936	1,574	1,051	925.63	729.86	205.84
Total Assets	37,495	33,509	31,192	26,996	24,201	21,464
Accounts Payable	7,624	6,102	5,902	4,520	4,501	4,402
Accrued Expenses	208.74	554.92	518.92	920.63	528.8	475.47
Short-Term Debt	1,833	1,197	1,337	1,627	1,808	1,048
Current Portion of Long-Term Debt	378.43	80.92	36.9	174.18	40.05	1,028
Current Portion of Leases	-	81.98	75.29	66.86	-	-
Current Income Taxes Payable	536.52	259.27	154.95	261.24	166.43	152.85
Current Unearned Revenue	129.88	136.85	147.64	119.49	95.34	254.89
Other Current Liabilities	3,622	2,389	1,979	1,576	1,494	1,035
Total Current Liabilities	14,333	10,803	10,153	9,266	8,634	8,397
Long-Term Debt	67.98	520.76	1,051	139.18	151.61	-
Long-Term Leases	88.78	56.7	84.61	80.89	-	-
Long-Term Unearned Revenue	147.31	171.06	126.12	83.52	81.63	60.96
Long-Term Deferred Tax Liabilities	180.09	184.37	202.08	184.91	88.74	39.6
Other Long-Term Liabilities	107.63	191.61	398.67	300.99	66.28	100.15
Total Liabilities	14,925	11,927	12,016	10,055	9,022	8,597
Common Stock	1,754	1,754	1,754	1,750	1,750	1,750
Additional Paid-In Capital	2,488	2,446	2,378	2,230	2,158	2,158
Retained Earnings	17,903	16,972	14,639	12,647	10,714	8,379
Treasury Stock	-80.46	-84.52	-104.65	-	-	-
Comprehensive Income & Other	-22.67	-40.34	-88.55	-47.77	-2.19	22.79
Total Common Equity	22,041	21,048	18,578	16,579	14,620	12,309
Minority Interest	529.12	534.65	598.52	361.94	559.59	557.15
Shareholders' Equity	22,570	21,582	19,176	16,941	15,179	12,867
Total Liabilities & Equity	37,495	33,509	31,192	26,996	24,201	21,464
Total Debt	2,369	1,938	2,586	2,089	1,999	2,076
Net Cash (Debt)	2,371	2,726	1,411	1,944	1,199	326.58
Net Cash Growth	3.87%	93.21%	-27.43%	62.16%	267.04%	-24.45%
Net Cash Per Share	1.35	1.56	0.81	1.11	0.69	0.19
Filing Date Shares Outstanding	1,743	1,752	1,750	1,750	1,750	1,750
Total Common Shares Outstanding	1,743	1,752	1,750	1,750	1,750	1,750
Working Capital	6,920	7,694	7,415	6,221	6,022	5,339
Book Value Per Share	12.64	12.01	10.62	9.47	8.36	7.03
Tangible Book Value	16,584	16,115	13,856	12,207	11,687	9,385
Tangible Book Value Per Share	9.51	9.20	7.92	6.98	6.68	5.36
Buildings	-	2,299	1,865	1,503	1,228	1,211
Machinery	-	4,438	4,282	3,385	2,817	2,329
Construction In Progress	-	913.15	873.16	1,582	2,240	1,830

Source: S&P Capital IQ. Standard template. Financial Sources.